Attentional Bias Modification Training for Quitting Smoking
Trial Summary
What is the purpose of this trial?
Aims are to (1) evaluate attentional bias to e-cigarette cues between the intervention and control groups at post-intervention as compared to the pre-intervention; and (2) test the feasibility and efficacy of the intervention at post-intervention. To accomplish these aims, a theory-driven parallel, controlled 2-arm randomized clinical trial will be conducted with young adult e-cigarette users (approximately N = 50). Outcomes are attentional bias to e-cigarette cues and abstinence outcomes including nicotine dependence, and arousal/urges for e-cigarette use.
Research Team
Seok Hyun Gwon, PhD, RN
Principal Investigator
University of Wisconsin, Milwaukee
Eligibility Criteria
This trial is for young adults aged 18-29 who exclusively use e-cigarettes (ENDS) and have been doing so for at least 3 months. Participants must own a smartphone but cannot be on medication or psychosocial treatment for ENDS dependence, pregnant, have serious alcohol issues, eye-tracking problems, or current psychiatric treatment for DSM-5 mental health disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo attentional bias modification training or placebo attention control training
Follow-up
Participants are monitored for attentional bias, nicotine dependence, and subjective urges for e-cigarette use
Treatment Details
Interventions
- Computerized attentional bias modification training
- Placebo attention control training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Milwaukee
Lead Sponsor